Jefferies sent Ziel für Pfizer for 33 Dollars – ‘Buy’ ()

NEW YORK (dpa-AFX Analyzer) – The analysis house of Jefferies has risen from 35 to 33 US dollars, after purchasing a “buy” price. Analyst Akash Tewari has commented in his spare time on the results of Mittel Oxbryta on his research model, following the Pharmakonzern Oxbryta of all markets consulted./ajx/ag Veröffentlichung der Original-Studie: 26.09.2024 / 22:51 / ET First Review of the Original Study: 26.09.2024 / 22:51 / ET Hinweis: Informationen zur Offenlegungspflicht bei Interessenkonflikten im Sinne von § 85 Abs. 1 WpHG, art. 20 VO (EU) 596/2014 for the generated analyst house can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.